Ortotaškas, MB - financials and debts

Company age: 6 y. 6 mo.

Update

Ortotaškas - Company finances

EUR
2020
From: 2020-03-02
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,611 5,502 15,045 23,025 22,703 26,513
Profit before tax -4,782 -7,891 -7,943 -2,456 -9,010 2,986
Net profit -4,782 -7,891 -7,943 -2,456 -9,010 2,986
Equity -2,782 -10,673 -18,616 -21,073 -30,083 -27,096
Liabilities - - 33,078 41,858 56,146 63,890
Non-current assets 0 3,485 3,018 3,920 2,916 2,053
Current assets 2,750 4,541 11,444 16,865 23,147 34,741
Total assets 2,750 8,026 14,462 20,785 26,063 36,794
Taxes paid
STI taxes - - - 677 453 1,287
Financial indicators
Revenue change y/y - +110.7% +173.4% +53.0% -1.4% +16.8%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -173.9% -98.3% -54.9% -11.8% -34.6% 8.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - - -
Profit margin Net profit margin. Shows the overall profitability of the company. -183.1% -143.4% -52.8% -10.7% -39.7% 11.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -183.1% -143.4% -52.8% -10.7% -39.7% 11.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - 15,045 23,025 22,703 26,513

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Ortotaškas - Social security debts

From To Debt, €
2026-01-01 2026-01-13 0.22
2025-12-16 2025-12-30 0.22
2025-11-18 2025-12-14 0.22
2025-10-23 2025-11-16 0.22
2025-09-07 2025-09-11 14.68
2025-08-31 2025-09-03 14.68
2025-08-19 2025-08-29 14.68
2025-07-24 2025-08-17 14.68
2025-07-16 2025-07-23 14.57
2025-07-15 2025-07-15 0.01
2025-06-17 2025-07-14 14.57
2025-06-11 2025-06-16 0.01
2025-06-08 2025-06-09 0.01
2025-05-16 2025-06-04 0.01
2025-05-04 2025-05-14 0.01
2025-04-24 2025-04-29 0.01
2025-01-16 2025-01-19 10.91
2024-10-24 2024-12-15 0.19
2024-09-17 2024-09-22 10.92
2024-08-19 2024-09-10 9.61
2024-07-24 2024-08-13 9.61
2024-07-17 2024-07-23 9.47
2024-07-16 2024-07-16 24.03
2024-06-28 2024-07-15 9.47
2024-06-18 2024-06-27 9.46
2024-05-16 2024-05-30 12.04
2023-08-17 2023-08-29 10.97
2023-06-16 2023-06-18 14.61
2023-05-17 2023-06-15 0.05
2023-05-16 2023-05-16 14.61
2023-05-02 2023-05-15 0.05
2023-04-25 2023-04-28 0.05
2023-02-17 2023-03-01 3.77
2023-02-06 2023-02-14 3.74
2023-01-20 2023-02-03 3.74
2023-01-17 2023-01-19 3.63
2023-01-03 2023-01-15 3.63
2022-12-16 2023-01-02 18.01
2022-11-21 2022-12-15 0.02
2022-11-17 2022-11-18 0.02
2022-10-28 2022-11-14 0.02

Ortotaškas - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Ortotaškas, MB (company code 305487700) is a Lithuanian small partnership engaged in the retail sale of other medical and orthopaedic goods. In 2025, the company generated revenue of €26.5K, up 16.8% year on year and 15.2% over two years. After a loss of €9.0K in 2024 and a smaller loss of €2.5K in 2023, net profit turned positive in 2025 at €3.0K, giving a profit margin of 11.3%. The revenue trend shows a dip from €23.0K in 2023 to €22.7K in 2024, followed by recovery in 2025. At year-end 2025, total assets stood at €36.8K, with short-term assets of €34.7K and long-term assets of €2.1K. Equity remained negative at -€27.1K, while liabilities increased to €63.9K. Key ratios show asset turnover of 0.72x and ROA of 8.1%; profitability improved, although the capital structure remained weak because of negative equity. Revenue per employee was €26.5K and profit per employee €3.0K in 2025.